On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity

Oleg Kovrov, Kristian Kølby Kristensen, Erika Larsson, Michael Ploug, Gunilla Olivecrona

    39 Citationer (Scopus)

    Abstract

    Angiopoietin-like (ANGPTL) 8 is a secreted inhibitor of LPL, a key enzyme in plasma triglyceride metabolism. It was previously reported that ANGPTL8 requires another member of the ANGPTL family, ANGPTL3, to act on LPL. ANGPTL3, much like ANGPTL4, is a physiologically relevant regulator of LPL activity, which causes irreversible inactivation of the enzyme. Here, we show that ANGPTL8 can form complexes with either ANGPTL3 or ANGPTL4 when the proteins are refolded together from their denatured states. In contrast to the augmented inhibitory effect of the ANGPTL3/ANGPTL8 complex on LPL activity, the ANGPTL4/ANGPTL8 complex is less active compared with ANGPTL4 alone. In our experiments, all three members of the ANGPTL family use the same mechanism to inactivate LPL, which involves dissociation of active dimeric LPL to monomers. This inactivation can be counteracted by the presence of glycosylphosphatidylinositol-anchored HDL binding protein 1, the endothelial LPL transport protein previously known to protect LPL from spontaneous and ANGPTL4-catalyzed inactivation. Our data demonstrate that ANGPTL8 may function as an important metabolic switch, by forming complexes with ANGPTL3, or with ANGPTL4, in order to direct the flow of energy from triglycerides in blood according to the needs of the body.

    OriginalsprogEngelsk
    TidsskriftJournal of Lipid Research
    Vol/bind60
    Udgave nummer4
    Sider (fra-til)783-793
    Antal sider11
    ISSN0022-2275
    DOI
    StatusUdgivet - 2019

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'On the mechanism of angiopoietin-like protein 8 for control of lipoprotein lipase activity'. Sammen danner de et unikt fingeraftryk.

    Citationsformater